AstraZeneca is a company in IT decline - Recensione dipendente - Solutions Architect presso AstraZeneca

3,0
6 nov 2012
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

People are dedicated, motivated and intelligent. Employee compensation is very good.

Svantaggi

Company has no R&D to speak of with limited prospects near term. Financials are driving re-organizations across the company. Talented folks are being let go. IT innovation is starting to develop but that will take a few more years.

Esplora altre recensioni su AstraZeneca

5,0
17 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

great place to work and develop!

Svantaggi

could maybe have more transparency

1,0
19 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The page is friendly to make an application.

Svantaggi

As an experienced healthcare analytics and commercial leader, I applied to 104 U.S.-based positions at AstraZeneca between 2025 and 2026 that closely matched my background. Despite receiving interviews from peer organizations, I did not receive a single recruiter interaction. I fully understand the competitiveness of hiring, but such a complete lack of engagement raises questions about potential overreliance on AI screening or unintended bias.

Vedi recensioni per: Utile|Valutazione|Data|Tutto